buyWeak
Braden Michael Leonard bought $588k of ADVM
owner at Adverum Biotechnologies, Inc.. 117,941 shares at an average of $4.98, traded Mar 18, 2025, filed Mar 20, 2025.
Conviction score
31Value
$588k
117,941 shares
Holdings after
2,722,761
+5% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +19Trade size$588k at market
- 0Relative to holdingsHoldings up 4.5%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001373604-25-000051, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 18, 2025 | POpen-market purchase Common Stockindirect: Holding of BML Investment Partners, L.P. | +18,000 | $4.60 | $83k | 2,622,820 | Mar 20, 2025 |
| Mar 18, 2025 | POpen-market purchase Common Stockindirect: Holding of BML Investment Partners, L.P. | +44,341 | $4.73 | $210k | 2,667,161 | Mar 20, 2025 |
| Mar 19, 2025 | POpen-market purchase Common Stockindirect: Holding of BML Investment Partners, L.P. | +25,000 | $4.94 | $123k | 2,692,161 | Mar 20, 2025 |
| Mar 20, 2025 | POpen-market purchase Common Stovkindirect: Holding of BML Investment Partners, L.P. | +30,600 | $5.61 | $172k | 2,722,761 | Mar 20, 2025 |
Related signals
Other insiders at Adverum Biotechnologies, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 62Notable | Adverum Biotechnologies, Inc. | Laurent Fischer CEO, PRESIDENT AND DIRECTOR | $554k 128,699 shares | +177% | |
| 50Moderate | Adverum Biotechnologies, Inc. | Peter Soparkar CHIEF OPERATING OFFICER | $211k 50,000 shares | +166% | |
| 42Moderate | ADVMsell Adverum Biotechnologies, Inc. | Braden Michael Leonard owner | $2.2M 524,560 shares | -21% | |
| 42Moderate | ADVMsell Adverum Biotechnologies, Inc. | Braden Michael Leonard owner | $2.4M 574,886 shares | -19% | |
| 40Moderate | Adverum Biotechnologies, Inc. | Laurent Fischer CEO, PRESIDENT AND DIRECTOR | $18k 9,126 shares | -9% | |
| 30Weak | Adverum Biotechnologies, Inc. | Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER | $1,848 924 shares | -6% | |
| 35Weak | Adverum Biotechnologies, Inc. | Peter Soparkar CHIEF OPERATING OFFICER | $5,920 2,960 shares | -7% | |
| 30Weak | ADVMbuy Adverum Biotechnologies, Inc. | Braden Michael Leonard owner | $189k 37,000 shares | +35% | |
| 30Weak | ADVMbuy Adverum Biotechnologies, Inc. | Braden Michael Leonard owner | $189k 37,000 shares | +35% | |
| 40Moderate | ADVMbuy Adverum Biotechnologies, Inc. | Braden Michael Leonard owner | $1.0M 350,000 shares | +13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.